BridgeBio to Participate in September Investor Conferences

Core Insights - BridgeBio Pharma, Inc. is a biopharmaceutical company focused on developing transformative medicines for genetic diseases [2] - The company will participate in several healthcare investor conferences, showcasing its commitment to engaging with investors [1][3] Company Overview - Founded in 2015, BridgeBio aims to discover, create, test, and deliver medicines for patients with genetic diseases [2] - The company's pipeline includes programs from early science to advanced clinical trials, indicating a robust development strategy [2] Upcoming Events - BridgeBio will host a fireside chat at the Wells Fargo Healthcare Conference on September 3 at 9:30 am ET [3] - The company will also participate in the Cantor Global Healthcare Conference on September 4 at 2:10 pm ET [3] - Additionally, a fireside chat is scheduled for the Morgan Stanley Global Healthcare Conference on September 8 at 3:20 pm ET [3]